Tri-City, County Agree on Mental Health Funding

MEDICINE: New Reimbursement Mechanism May Serve as Model for Other Hospitals

A recent deal between Tri-City Medical Center and San Diego County could serve as a new model in funding mental health at hospitals, one potential solution to a strained psychiatric system.

Tease photo

Executive Recruitment Firm Expands in BioLabs

Executive search firm Bench International has taken up residence in the San Diego incubator space run by BioLabs.

Tocagen to Conduct ‘Operational Review’ After Clinical Trial

Biotech’s Brain Cancer Treatment Posts Disappointing Results

In 2017, Tocagen raised $87 million in a public offering. Investors saw potential in the San Diego biotech’s combo treatment for recurrent brain cancer.

Amplyx Adds to Pipeline, Unveils Clinical Trial Data

Data Committee Finds ‘High Level of Treatment Success’

Amplx Pharmaceuticals recently revealed promising data for a drug designed to treat life-threatening infections.

Metacrine Secures $50M Loan and Security Deal

San Diego-based Metacrine has inked a loan and security agreement for up to $50 million with K2 HealthVentures.

Pursuing ‘Untapped Biology,’ Boundless Bio Lands $46.4M Funding Round

Boundless Bio Inc. emerged Sept. 19 with $46.4 million in funding and a claim to new territory: extrachromosomal DNA

Acadia Pharmaceuticals Plans $250M Stock Offering

Acadia Pharmaceuticals is planning to raise $250 million through a public stock offering.

$161B Market Seen in ‘Functional Foods’

HEALTH: Consumer Focus on Nutrition Drives Demand

More and more, San Diego-based food companies are placing focus on including functional ingredients in their “better for you” offerings.

Tease photo

DelMar Pharmaceuticals Relocates to San Diego

DelMar Pharmaceuticals has relocated from British Columbia to San Diego.

SGI-DNA Pulls in $25M Series A Round for DNA Printer

San Diego’s SGI-DNA, a spinout of Synthetic Genomics, has raised a $25 million series A round.

Company Has Instrument of Change for Dermatology

MEDICINE: DermTech’s Patch May Change Skin Cancer Diagnostics

Could that suspicious mole be cancerous? DermTech wants doctors to reach for a patch, not a scalpel.

Tease photo

SDBJ INSIDER: The Wait May Soon Be Over

Obalon Therapeutics Inc. announced Dr. Helmuth Billy as medical director for its first company-owned weight-loss treatment center.

Turning Point Therapeutics Raises $202.5M in Follow-On Offering

BIOTECH: Cancer Drug Developer Plans To Build Its Pipeline

After raising $175.2 million in an initial public offering this spring, Turning Point Therapeutics has returned to the public market.

Tease photo

Tocagen’s Brain Cancer Therapy Fails Clinical Trial

Shares of Tocagen fell Sept. 12 after its brain cancer therapy failed a late-stage clinical trial.

Turning Point Therapeutics Raises $202.5M in Follow-On Offering

The cancer drug developer on Sept. 10 raised $202.5 million in a follow-on offering. Turning Point sold 4.5 million shares of common stock at a price of $45 a share.